Cyclo Therapeutics Stock Operating Margin
| CYTHDelisted Stock | USD 0.72 0.06 9.09% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Cyclo Therapeutics' long-term financial health and intrinsic value.
Cyclo |
Cyclo Therapeutics Company Operating Margin Analysis
Cyclo Therapeutics' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Cyclo Therapeutics Operating Margin | (35.46) % |
Most of Cyclo Therapeutics' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cyclo Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Cyclo Therapeutics has an Operating Margin of -35.4595%. This indicator is about the same for the Biotechnology average (which is currently at -35.08) sector and significantly lower than that of the Health Care industry. The operating margin for all United States stocks is notably higher than that of the company.
Cyclo Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cyclo Therapeutics' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cyclo Therapeutics could also be used in its relative valuation, which is a method of valuing Cyclo Therapeutics by comparing valuation metrics of similar companies.Cyclo Therapeutics is currently under evaluation in operating margin category among its peers.
Cyclo Fundamentals
| Return On Equity | -226.64 | |||
| Return On Asset | -2.84 | |||
| Operating Margin | (35.46) % | |||
| Current Valuation | 34.87 M | |||
| Shares Outstanding | 32.74 M | |||
| Shares Owned By Insiders | 48.45 % | |||
| Shares Owned By Institutions | 11.44 % | |||
| Number Of Shares Shorted | 736.31 K | |||
| Price To Book | 59.10 X | |||
| Price To Sales | 27.09 X | |||
| Revenue | 1.08 M | |||
| Gross Profit | 794.48 K | |||
| EBITDA | (20.03 M) | |||
| Net Income | (20.06 M) | |||
| Cash And Equivalents | 4.29 M | |||
| Cash Per Share | 0.51 X | |||
| Total Debt | 1.03 M | |||
| Current Ratio | 2.93 X | |||
| Book Value Per Share | (0.47) X | |||
| Cash Flow From Operations | (16.19 M) | |||
| Short Ratio | 5.58 X | |||
| Earnings Per Share | (0.90) X | |||
| Target Price | 0.95 | |||
| Beta | -0.57 | |||
| Market Capitalization | 23.59 M | |||
| Total Asset | 13.25 M | |||
| Retained Earnings | (83.86 M) | |||
| Working Capital | 3.85 M | |||
| Net Asset | 13.25 M |
About Cyclo Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cyclo Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cyclo Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cyclo Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Cyclo Stock
If you are still planning to invest in Cyclo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cyclo Therapeutics' history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |